...
首页> 外文期刊>Diabetes, metabolic syndrome and obesity: targets and therapy >Impacts of Pre-Diabetes or Prehypertension on Subsequent Occurrence of Cardiovascular and All-Cause Mortality among Population without Cardiovascular Diseases
【24h】

Impacts of Pre-Diabetes or Prehypertension on Subsequent Occurrence of Cardiovascular and All-Cause Mortality among Population without Cardiovascular Diseases

机译:糖尿病患者或前嗜疗法对随后发生的心血管和所有导致死亡率的影响,没有心血管疾病

获取原文
           

摘要

Background: Among the population without cardiovascular diseases (CVD), it is unclear whether pre-diabetes and/or prehypertension elevated the risk of all-cause and cardiovascular mortality. Methods: All participants without CVD at baseline were recruited from the 1999– 2014 National Health and Nutrition Examination Survey (NHANES), with survival status being updated until 31 December 2015. Cox proportional hazards models and subgroup analyses were performed to estimate hazard ratios (HRs) and 95% confidence interval (CI). Results: There were 23,622 participants (11,233 [47.6%] male) with mean age of 37.2 years. Compared to participants without prehypertension or pre-diabetes, the HRs for all-cause mortality among participants with prehypertension alone, pre-diabetes alone, and combined pre-diabetes and prehypertension were 1.04 (95% CI: 0.88, 1.24), 0.96 (95% CI:0.76, 1.21), and 1.19 (95% CI:0.98, 1.46), respectively. The corresponding HRs for cardiovascular mortality were 1.51 (95% CI: 0.83, 2.77), 1.40 (95% CI: 0.64, 3.06), and 1.70 (95% CI: 0.88, 3.27), respectively. A subgroup analysis showed that participants with combined pre-diabetes and prehypertension had a higher risk of all-cause mortality among younger participants, higher BMI, white population, and people with elevated non-HDLC. Moreover, the association between combined pre-diabetes and prehypertension and cardiovascular death was only significant among people with elevated non-HDLC. Conclusion: Pre-diabetes combined with prehypertension might elevate the risk of all-cause mortality among subjects, particularly for those with elevated body weight, high non-HDLC, younger participants or white population.
机译:背景:在没有心血管疾病的人群中(CVD),目前还不清楚糖尿病患者和/或毛细血管患者是否升高了所有原因和心血管死亡率的风险。方法:从1999年至2014年国家卫生和营养考试调查(NHANES)招募了基线的所有参与者,并在2015年12月31日之前进行了生存状态。进行了COX比例危害模型和亚组分析以估算危险比率(HRS )和95%置信区间(CI)。结果:有23,622名参与者(11,233 [47.6%]男性),平均年龄为37.2岁。与参与者没有患者或糖尿病前患者,单独患有毛细管前的参与者的所有因果死亡率,单独前糖尿病和组合的糖尿病患者和蛋白质的孕前和毛细血管均为1.04(95%CI:0.88,1.24),0.96(95 %CI:0.76,1.21)和1.19(95%CI:0.98,1.46)。心血管死亡率的相应HRS分别为1.51(95%CI:0.83,2.77),1.40(95%CI:0.64,3.06)和1.70(95%CI:0.88,3.27)。亚组分析表明,糖尿病患者和毛发育的参与者具有更高的参与者,更高的BMI,白人人口和升高的非HDLC的人们的死亡率较高。此外,组合前糖尿病患者和心血管死亡和心血管死亡之间的关联仅为非HDLC升高的人群。结论:糖尿病患者结合毛细血管,可能会提高受试者中所有因素死亡率的风险,特别是对于体重升高,非HDLC,年轻参与者或白人人口的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号